Vance takes on a more visible transition role, working to boost Trump’s most contentious picksRoundup: Book leads Rockets past Berries in SR Holiday ClassicSTUART, Fla. , Dec. 24, 2024 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, today announced the closing of its initial public offering of 2,300,000 shares of its Class A common stock at a public offering price of $4.00 per share, for gross proceeds of $9,200,000 , before deducting underwriting discounts, commissions, and estimated offering expenses. The Company has granted the underwriter an option, exercisable within 30 days from the date of the final prospectus, to purchase an additional 345,000 shares of Class A common stock from Health In Tech at the initial public offering price, less underwriting discounts and commissions. Assuming such option is fully exercised, the Company may raise a total of approximately US$10,580,000 in gross proceeds from the Offering Health In Tech intends to use the net proceeds from the offering for system enhancements, expansion of service offerings, sales and distribution channels, talent development and retention, working capital, and other general corporate purposes. American Trust Investment Services, Inc. acted as the sole book-running manager for the offering. A registration statement on Form S-1 (File No. 333-281853) relating to the shares was filed with the Securities and Exchange Commission and became effective on December 19, 2024 . This offering was made only by means of a prospectus, forming part of the effective registration statement. A copy of the prospectus relating to the offering can be obtained when available, by contacting American Trust Investment Services, Inc., 230 W. Monroe Street , Suite 300, Chicago, IL 60606, or via E-Mail at ECM@amtruinvest.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Health In Tech Health in Tech ("HIT") is an Insurtech platform company backed by third-party AI technology. We offer a dynamic marketplace designed to create customized healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. By eliminating friction and complexities, HIT enhances value propositions for employers and optimizes underwriting, sales, and service workflows for Managing General Underwriters (MGUs), insurance carriers, licensed brokers, and Third-Party Administrators (TPAs). Learn more at healthintech.com . Forward-Looking Statements Regarding Health In Tech Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Investor Contact Investor Relations: ir@healthintech.com View original content to download multimedia: https://www.prnewswire.com/news-releases/health-in-tech-announces-closing-of-initial-public-offering-302338923.html SOURCE Health In Tech
Nick Kyrgios has described Jannik Sinner and Iga Swiatek’s positive doping tests as “disgusting” ahead of his return to tennis. The controversial Australian has played only one match in more than two years because of injury but that has not stopped him being an outspoken presence on social media during a difficult few months for the sport. First it was announced in August that Sinner had failed two doping tests in March but was cleared of fault, while in November Swiatek was handed a one-month ban for a failed test caused by contaminated medication. Feels good getting these consecutive days training in the bank man.... Wrist re construction and back out here... blessed..................Without failing any drug tests 🙂↕️🙏🏽 be proud kygs doing it the right way 😩😂 pic.twitter.com/J8l21lnTdI — Nicholas Kyrgios (@NickKyrgios) December 5, 2024 Kyrgios has been particularly vociferous in his criticism of Sinner, who could yet face a ban after the World Anti-Doping Agency appealed the finding of no fault or negligence in his case. At a press conference ahead of the Brisbane International, Kyrgios told reporters: “I have to be outspoken about it because I don’t think there’s enough people that are speaking about it. I think people are trying to sweep it under the rug. “I just think that it’s been handled horrifically in our sport. Two world number ones both getting done for doping is disgusting for our sport. It’s a horrible look. “The tennis integrity right now – and everyone knows it, but no one wants to speak about it – it’s awful. It’s actually awful. And it’s not OK.” Kyrgios initially underwent knee surgery in January 2023, returning to action in June of that year, but he played only one match before pulling out of Wimbledon due to a torn ligament in his right wrist. He has not played a competitive match since, and it appeared doubtful that he would be able to return, but the 29-year-old will make his comeback in Brisbane this week. Kyrgios will take on France’s Giovanni Mpetshi Perricard in singles, while he will also team up with Novak Djokovic in a blockbuster doubles pairing. “It’s good to be back,” said Kyrgios. “I honestly never thought I’d be back playing at this level. Even entering an event like this, preparing, doing all the right things. A post shared by Nick Kyrgios (@k1ngkyrg1os) “I’m really excited to just go out there and play, just play tennis. I saw Novak in the gym, playing doubles with him, a lot to be excited about that I’m able to get out there and compete again.” Asked whether he could get back to the same level that saw him reach the Wimbledon final in 2022, Kyrgios said: “I still believe I can, whether or not that’s factual or not. There was another player who was like, ‘You have to be realistic’. That’s not how I am. I always back my ability.” The new tennis season is already under way, with the United Cup team event beginning on Friday. Great Britain, who are weakened by the absence of Jack Draper through injury, begin their campaign against Argentina in Sydney on Monday before facing hosts Australia on Wednesday. That could pit Katie Boulter against fiance Alex De Minaur, with the pair having announced their engagement last week. A post shared by Katie Boulter (@katiecboulter) “Obviously some incredible news from our side, but I think we kind of wanted it to die down a little bit before matches started,” said Boulter of the timing. “My private life is out in the public a little bit at the moment. But, in terms of the stuff that I’m doing on the court, I’ll be doing the best I can every single day to stay in my own little bubble.” Billy Harris has taken Draper’s place, with the British number one facing a race against time to be fit for the Australian Open because of a hip problem. Emma Raducanu is the sixth seed at the ASB Classic in Auckland and will begin her season with a match against Robin Montgomery, while Cameron Norrie takes on another American, Learner Tien, at the Hong Kong Open.
George Kenneth BrandalickAmber Heard criticises social media in response to Blake Lively complaint
PCC green lights $3.3-B LNG facility, with conditions2024 in pop culture: In a bruising year, we sought out fantasy, escapism — and cute little animals
NEW YORK--(BUSINESS WIRE)--Dec 6, 2024-- DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular November monthly distribution. Details are as follows: Declaration – 12/06/2024 Ex-Date – 12/18/2024 Record – 12/18/2024 Payable – 12/30/2024 Fund Ticker Distribution Per Share Prior Distribution Per Share DWS Municipal Income Trust KTF $0.0610 $0.0610 The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly distributions and to distribute any realized capital gains at least annually. In addition, in any monthly period, to maintain its declared per common share distribution amount, the Fund may distribute more or less than its net investment income during the period. In the event the Fund distributes more than its net investment income during any yearly period, such distributions may also include realized gains and/or a return of capital. When distributions exceed total return performance, the difference will reduce the Fund’s net asset value. It is estimated that a portion of the Fund’s December distribution consists of a return of capital. A return of capital may occur, for example, when some or all of a shareholder’s investment is paid back to the shareholder. A return of capital distribution does not necessarily reflect a fund’s investment performance and should not be confused with “yield” or “income.” Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of its monthly distribution. As required by Federal securities laws, the Fund will issue a notice to its common shareholders in connection with its monthly distribution that contains information about the amount and estimated sources of the distribution and other related information. The final determination of the source and tax status of all distributions paid in 2024 will be made after the end of 2024 and will be provided on Form 1099-DIV. Important Information DWS Municipal Income Trust. Bond investments are subject to interest-rate, credit, liquidity and market risks to varying degrees. When interest rates rise, bond prices generally fall. Credit risk refers to the ability of an issuer to make timely payments of principal and interest. Municipal securities are subject to the risk that litigation, legislation or other political events, local business or economic conditions or the bankruptcy of the issuer could have a significant effect on an issuer’s ability to make payments of principal and/or interest. The market for municipal bonds may be less liquid than for taxable bonds, and there may be less information available on the financial condition of issuers of municipal securities than for public corporations. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Leverage results in additional risks and can magnify the effect of any gains or losses. Although the Fund seeks income that is exempt from federal income taxes, a portion of the Fund’s distributions may be subject to federal, state and local taxes, including the alternative minimum tax. Closed-end funds, unlike open-end funds, are not continuously offered. There is a one-time public offering and once issued, shares of closed-end funds are bought and sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to the net asset value. The price of a fund’s shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, the fund cannot predict whether its shares will trade at, below or above net asset value. Past performance is no guarantee of future results. This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. Certain statements contained in this release may be forward-looking in nature. These include all statements relating to plans, expectations, and other statements that are not historical facts and typically use words like “expect,” “anticipate,” “believe,” “intend,” ”estimated” and similar expressions. Such statements represent management’s current beliefs, based upon information available at the time the statements are made, with regard to the matters addressed. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Management does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. The following factors, among others, could cause actual results to differ materially from forward-looking statements: (i) the effects of adverse changes in market and economic conditions; (ii) legal and regulatory developments; and (iii) other additional risks and uncertainties, including public health crises (including the pandemic spread of viruses), war, terrorism, trade disputes and related geopolitical events. War, terrorism, sanctions, economic uncertainty, trade disputes, public health crises and related geopolitical events have led, and, in the future, may lead to significant disruptions in US and world economies and markets, which may lead to increased market volatility and may have significant adverse effects on the Fund and its investments. NOT FDIC/ NCUA INSURED • MAY LOSE VALUE • NO BANK GUARANTEE NOT A DEPOSIT • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY DWS Distributors, Inc. 222 South Riverside Plaza Chicago, IL 60606-5808 www.dws.com Tel (800) 621-1148 © 2024 DWS Group GmbH & Co. KGaA. All rights reserved. The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-103920 -1) (12/24) View source version on businesswire.com : https://www.businesswire.com/news/home/20241206189075/en/ CONTACT: For additional information: DWS Press Office (212) 454-4500 Shareholder Account Information (800) 294-4366 DWS Closed-End Funds (800) 349-4281 KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ASSET MANAGEMENT PROFESSIONAL SERVICES FINANCE SOURCE: DWS Distributors, Inc. Copyright Business Wire 2024. PUB: 12/06/2024 04:35 PM/DISC: 12/06/2024 04:36 PM http://www.businesswire.com/news/home/20241206189075/enChris Jericho Dishes on Facing Fellow WWE Alum Matt Cardona